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Abstract 
Gestational diabetes mellitus (GDM) is on the rise, 
especially with the increase in obesity in childbearing 
women as well as the rising prevalence of diabetes 
mellitus type 2.  The Maltese gestational women are of 
no exception especially with an established link to intra-
uterine nutritional environment adverse effects as well as 
to genetic factors.  
There is no set international screening strategy for 
GDM and so diagnosis differs between countries.  The 
most common diagnostic test for GDM is by performing 
a 75g oral glucose tolerance test (oGTT). Most countries 
and organizations including the World Health 
Organization have adopted the International Association 
of Diabetes and Pregnancy Study Groups (IADPSG) 
criteria for diagnosing GDM.  
Performing a 75g OGTT on all women at risk of 
GDM is expensive as well as unpleasant for the women. 
A combination of risk criteria including pre-pregnancy 
body mass index with random plasma glucose and/or 
fasting plasma glucose based on Maltese and 
Mediterranean population studies have shown to be a 
useful screening tool. This tool would help identify 
women likely to have an abnormal or normal oGTT 
without the need to perform an oGTT.  
A screening GDM protocol is essential to pick up 
and manage at an early stage those that are at risk to 
develop GDM without the need to have an oGTT 
performed in every pregnant woman. This would result 
in better perinatal and maternal outcomes.  
 
 
 
 
 
 
 
 
 
 
Keywords 
Diabetes, Gestational, guideline, risk factors, 
diagnosis 
 
Acknowledgments 
The research work disclosed in this publication is 
funded by the MASTER it! Scholarship Scheme (Malta). 
The scholarship is part-financed by the European Union 
– European Social Fund (ESF) under Operational 
Programme II – Cohesion Policy 2007 – 2013, 
“Empowering People for More jobs and a Better Quality 
of Life”. 
 
Introduction 
Gestational diabetes mellitus (GDM) is defined as 
either diabetes or glucose intolerance, which is initially 
recognized during pregnancy.1  
The prevalence of gestational diabetes is on the rise 
and has been greatly associated with the two current 
epidemics of type 2 diabetes mellitus and obesity in 
childbearing women.2 Cross-sectional studies conducted 
on Maltese population suggested that the prevalence 
based on the WHO criteria was 11.5% in 1983.3-4 This 
rate appears to have risen to 15.5% in 2010 using the 
same diagnostic criteria. This latter rate actually 
translates to 16.5% using the newly proposed IADPSG 
diagnostic criteria.5 
The Mediterranean population has been found to be 
susceptible to adiposity, making pregnant women more 
prone to hyperglycemia and development of insulin 
resistance leading to GDM.5 In Malta, GDM prevalence 
is on the rise especially with the high prevalence of 
obesity as well as Type 2 Diabetes mellitus.4 The high 
prevalence of obesity and diabetes mellitus in the 
Maltese population have been linked to intra-uterine 
nutritional environment adverse effects though genetic 
factors may also play a part.6 
 
Screening for GDM 
Screening for gestational diabetes has long become 
a common investigation performed by obstetricians 
during pregnancy. Using a risk based screening 
approach on “historic” and clinical criteria to identify 
risk pregnant women for GDM has been shown to be 
inappropriate. Studies performed on Maltese population 
using a risk factor screening criteria have shown a high 
specificity and negative predictive value with an overall 
moderate to low sensitivity and positive predictive value.7-8  
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Figure 1: Screening for diabetes during pregnancy Flow Chart 
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This was in keeping with other international 
studies.9-10 Therefore, since using risk factor criteria is 
not an ideal screening tool to identify GDM women, it 
has been recommended that universal screening with 
75g- oral glucose tolerance test (oGTT) should ideally 
be performed. This may not however be the most cost-
effective course of management.8 There is no set 
international screening strategy, so that screening 
programmes for GDM varies from one country to 
another.11 In a Mediterranean population, the 
Mediterranean Group for the Study of Diabetes (MGSD) 
GDM study has identified that risk criteria showing a 
huge specificity and specificity and thus useful for 
screening include an elevated pre-pregnancy or third 
trimester maternal BMI (>25 and >30 kg/m2 
respectively), a maternal age greater than 30 years, and a 
fasting plasma glucose [FBG] >5.1 mmol/l. All other 
previously described risk factors were found to be 
unsuitable with very low sensitivity values.12 An 
untimed plasma glucose value of >6.8 mmol/l or 
<4.5mmol/L may also be a useful screening tool to 
identify women likely to have an abnormal or normal 
oGTT.13 A proposed screening flowchart is outlined 
below (Figure 1). This proposed screening programme is 
based on the IADSG and WHO-2013 proposed cut-off 
criteria for the oGTT in pregnancy 1,14 supplemented by 
the MGSD epidemiological studies related to GDM 12 
and studies relating to the use of random plasma glucose 
[RBG] screening in the Maltese population.13 An 
arbitrary RBG cut-off point of >6.0 mmol/l has been 
adopted to reduce the number of patients being 
inconvenienced by being recalled for an FBG.  
 
Diagnostic criteria for GDM 
As there is no set international screening strategy, 
likewise the criteria used to diagnose GDM and the 
interpretation of the 75g oGTT varies from one country 
to another.11  
The most common GDM diagnostic test to be 
performed is the oral glucose tolerance test (oGTT), 
usually performed during the 24 – 28 weeks of 
gestation.15  If the mother is considered to be at a high 
risk to develop GDM, this test may be done much earlier 
in her pregnancy. Stratification whether the mother is at 
high risk or not, comes from the first antenatal visit to 
the obstetrician, where a detailed medical, family and 
past obstetric history and a physical examination would 
be performed.17 A fasting or untimed plasma glucose 
with or without a glycosated haemoglobin estimation 
may also be performed to identify early pre-pregnancy 
undiagnosed diabetic women. 
Over the years, different oGTT approaches and 
thresholds had been established. The 2-step approach 
takes its origin back to the 1964 O’ Sullivan et al. study 
which has been adapted over the years by different 
groups accordingly.18 This was subsequently adopted 
and modified by the American Diabetes Association 
(ADA).19 Many of the cut-off levels used to define GDM 
were based on 95% centile values of plasma glucose 
measures during an oGTT. The HAPO study carried out 
by the International Association of Diabetes and 
Pregnancy Study Groups (IADPSG) identified the cut-
off criteria by looking at neonatal outcome by glucose 
values. 20 Similar observations have been made in a 
Mediterranean population. The World Health 
Organization has now adopted the IADPSG criteria.14  
 
Conclusions 
Screening for GDM is essential since the 
management of these women has been shown to result in 
better perinatal and maternal outcomes. Two large 
randomized interventional trials have confirmed that 
intervention may reduce the risk for developing fetal 
overgrowth, shoulder dystocia, hypertensive disorders 
and caesarean delivery was established. 21-22 
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